|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACUTE CORONARY SYNDROMES |
1 Cardiac Magnetic Resonance Unit, Leeds General Infirmary, Leeds, UK
2 Academic Unit of Cardiovascular Medicine, University of Leeds, Leeds, UK
3 Department of Clinical Biochemistry, Leeds General Infirmary, Leeds, UK
4 Department of Medical Physics, Leeds General Infirmary, Leeds, UK
Correspondence to:
Dr J Greenwood, Senior Lecturer in Cardiology, Academic Unit of Cardiovascular Medicine, G Floor, Jubilee Wing, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK; j.greenwood{at}leeds.ac.uk
ABSTRACT
Objectives: The aim of this study was to use late gadolinium hyper-enhancement cardiac magnetic resonance (LGE-CMR) imaging to determine if a 72-h troponin-I measurement would provide a more accurate estimation of infarct size and microvascular obstruction (MVO) than serial creatine kinase (CK) or early troponin-I values.
Methods: LGE-CMR was performed 3.7±1.4 days after medical treatment for acute ST elevation or non-ST elevation myocardial infarction. Infarct size and MVO were measured and correlated with serum troponin-I concentrations, which were sampled 12 h and 72 h after admission, in addition to serial CK levels.
Results: Ninety-three patients, of whom 71 had received thrombolysis for ST elevation myocardial infarction, completed the CMR study. Peak CK, 12-h troponin-I, and 72-h troponin-I were related to infarct size by LGE-CMR (r = 0.75, p<0.0001; r = 0.56, p = 0.0003; r = 0.62, p<0.0001 respectively). Serum biomarkers demonstrated higher values in the group with MVO compared with those without MVO (Peak CK 3085±1531 vs 1471±1135, p<0.001; 12-h troponin-I 58.3±46.9 vs 33.4±40.0, p = 0.13; 72-h troponin-I 11.5±9.9 vs 5.5±4.6, p<0.005). The correlation between the extent of MVO and 12-h troponin-I was not significant (r = 0.16), in contrast to the other serum biomarkers (peak CK r = 0.44, p<0.0001; 72-h troponin-I r = 0.46, p = 0.0002).
Conclusion: A single measurement of 72-h troponin-I is similar to serial CK measurements in the estimation of both myocardial infarct size and extent of MVO, and is superior to 12-h troponin-I measurements.
Abbreviations: AMI, acute myocardial infarction; CK, creatine kinase; LGE-CMR, late gadolinium hyper-enhancement cardiac magnetic resonance; LV, left ventricular; MVO, microvascular obstruction; NSTEMI, non-ST elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST elevation myocardial infarction
This article has been cited by other articles:
![]() |
S. Chia, F. Senatore, O. C. Raffel, H. Lee, F. J. Th. Wackers, and I.-K. Jang Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 415 - 423. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |